Ousted FDA vaccine director calls Kennedy’s start ‘very scary’
Peter Marks, the Food and Drug Administration (FDA) official pressured to resign over his disagreements with Health and Human ...
STAT4h
Science panel’s advice for next dietary guidelines could be on collision course with MAHA
The Dietary Guidelines for America are due by the end of the year, but Trump administration statements raise doubts as to ...
Ousted Vaccine Chief Says RFK Jr.’s Team Sought Data to Justify Anti-Science Stance
Peter Marks says the new health secretary’s team wants to show vaccines aren’t safe while promoting dangerous and unproven ...
Fierce Pharma9h
GSK, Pfizer resolve RSV patent feud amid vaccine market uncertainty
As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...
Chapelboro10h
Here’s Where Jobs and Programs Are Being Cut at the Nation’s Top Health Agencies
Thousands of people were laid off Tuesday at the United States' top health agencies. Here are what positions and efforts were ...
Vermont Community Newspaper Group11h
FDA Delays Final Approval of Novavax COVID Vaccine
The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, ...
11 Stocks to Buy After the Biotech Bloodbath
The group had a bad week after turmoil at the FDA, continuing a long period of underperformance following the pandemic.
The Value of Moderna's mRNA Technology Is Obscured by Fears of a Hostile US Regulatory Environment
Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...
Bizcommunity on MSN1d
Sanofi-Novavax deal in jeopardy as FDA halts vaccine approval
Dr Sara Brenner, the FDA's principal deputy commissioner, has paused the approval process for Novavax's Covid-19 vaccine by ...
FDA delays full approval of Novavax COVID-19 vaccine even though it was on track for clearance
The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...
Healthcare: Policy Uncertainty Is Countered by Interest in Defensive Stocks
Moderna, Baxter, and Pfizer are our top healthcare picks.
FDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofAS
The US Food and Drug Administration was supposed to make a final decision about whether or not to approve Novavax's (NVAX) COVID-19 vaccine this week, but that deadline has passed with no clarity on ...